Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Ann Surg Oncol22 Oct 2026

Pancreatic cancer: occult spread in 1 in 4

In this prospective multicenter cohort, staging laparoscopy found occult metastases in 25% of imaging-M0 patients—including 20.6% with resectable disease—potentially sparing some patients a nonbeneficial resection.

J Gastrointest Surg21 Oct 2026

Primary closure after bile duct exploration: 0.4% leak

In this 743-patient single-center series, laparoscopic bile duct exploration achieved 95.6% stone clearance with a 0.4% bile-leak rate—reassuring results for surgeons considering T-tube-free closure.

HPB & Spleen19 Oct 2026

Robotic biliary resection for gallbladder cancer

A single-case report details robotic partial central hepatectomy and bile-duct resection with Roux-en-Y reconstruction for gallbladder adenocarcinoma—an example of a complex operation performed minimally invasively, not evidence that it is ready for routine use.

Ann Surg Oncol19 Oct 2026

High-risk biliary cancer: NAC linked to better survival

In resectable biliary tract cancer, clinical node positivity or CA19-9 ≥200 U/mL flagged early-recurrence risk; neoadjuvant chemotherapy was associated with better survival in this high-risk group.